© 2021 MJH Life Sciences™ and Opthalmology Times Europe. All rights reserved.
October 21, 2021
Home testing technology is proving to be a key advancement in monitoring and screening glaucoma patients.
October 20, 2021
Talk of lens selection and patient satisfaction dominated discussion during the Advanced IOLs Symposium; cost vs. benefit analysis emerges as a theme throughout the congress.
October 19, 2021
New strategies are considered for obtaining information from visual assessments while ensuring compliance from paediatric patients.
October 18, 2021
Results from Phase 3 trials of bispecific antibody faricimab demonstrate that it is more durable than currently available agents, and it has a good safety profile.
October 14, 2021
As the world comes together to shine a global spotlight on blindness and vision impairment on World Sight Day, several global organizations and companies are stepping up to increase awareness of eye health, including the importance of regular examinations by an ophthalmologist or optometrist.
October 13, 2021
A review of studies, presentations and discussions at ASRS 2021 in San Antonio, Texas.
October 11, 2021
At ASRS 2021, Dr David Boyer reported that pegcetacoplan used to treat geographic atrophy and administered in monthly or every-other-month regimens was well tolerated in patients in the phase 3 DERBY and OAKS studies.
October 11, 2021
Dr Arshad Khanani reported at ASRS 2021 that the Port Delivery System with ranibizumab, an investigational product that continuously delivers ranibizumab intravitreally, achieved results similar to those in patients treated with monthly ranibizumab injections for nAMD.
October 10, 2021
At ASRS 2021 in San Antonio, TX, Dr Richard B. Rosen reported that clinical optical coherence tomography (OCT) can image and measure macular surface macrophage cells.